A multitasking immune protein once pursued as a treatment to rev up the body’s defenses might work better at toning them down. The compound, called interleukin-2, can halt and even reverse aberrant immune reactions where standard treatment has failed, French and U.S. research teams report in the Dec. 1 New England Journal of Medicine.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.